In Canada, which ophthalmic antibiotic eye drop should be used as first‑line therapy for a hordeolum that is not improving with warm compresses and lid hygiene?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

First-Line Antibiotic Eye Drop for Hordeolum in Canada

For a hordeolum not improving with warm compresses and lid hygiene, use erythromycin or bacitracin ophthalmic ointment applied to the eyelid margins once or more times daily or at bedtime for a few weeks.

Rationale and Evidence

The 2024 Blepharitis Preferred Practice Pattern guideline from the American Academy of Ophthalmology provides clear direction for eyelid margin infections 1. While this guideline primarily addresses blepharitis, hordeola (styes) represent acute bacterial infections of the eyelid glands that follow similar treatment principles.

Why Ointment Over Drops

Topical antibiotic ointments—specifically bacitracin or erythromycin—are the recommended first-line agents because they:

  • Provide prolonged contact time with the infected eyelid margin
  • Are applied directly to the site of infection (the eyelid margin, not the conjunctival sac)
  • Have established safety profiles for eyelid use 1

Treatment Algorithm

  1. Continue warm compresses and lid hygiene as the foundation of therapy
  2. Add topical antibiotic ointment (erythromycin or bacitracin) to eyelid margins
  3. Application frequency: 1-4 times daily or at bedtime
  4. Duration: Few weeks, guided by clinical response
  5. Consider rotation: Use different antibiotic classes intermittently to prevent resistance 1

Why Not Other Options

Azithromycin ophthalmic solution showed efficacy for internal hordeolum in a 2023 Japanese study 2, but this represents newer evidence from a single retrospective study rather than guideline-level recommendations. It may be considered as an alternative, particularly for internal hordeolum.

Fluoroquinolone drops (ciprofloxacin, ofloxacin) should be reserved for more severe infections like bacterial keratitis to avoid promoting resistance 3, 4. They are overprescribed for simple hordeola.

Tobramycin/dexamethasone combinations are mentioned in guidelines but represent off-label use for blepharitis, not specifically for hordeola 1.

Important Caveats

  • Antibiotics may not improve outcomes: A 2022 retrospective study of 2,712 patients found that adding antibiotics to conservative measures for hordeola showed no increased likelihood of treatment success (adjusted RR 0.99,95% CI 0.96-1.02, P=0.489) 5. However, when conservative measures have already failed, antibiotic ointment remains the guideline-recommended next step.

  • Ointment application technique matters: Apply directly to the eyelid margin where the infection is located, not into the conjunctival sac like typical eye drops.

  • Treatment duration: The guideline recommends "a few weeks" with frequency and duration guided by severity and response 1. Don't stop too early even if improvement occurs.

  • Resistance prevention: Rotate between different antibiotic classes (e.g., alternate between erythromycin and bacitracin courses) rather than using the same agent repeatedly 1.

Canadian Context

Both erythromycin and bacitracin ophthalmic ointments are available in Canada and align with the guideline recommendations. These remain appropriate first-line choices when conservative management fails.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.